Compound information
- Natural Products
- ZC650126
- Molecular Formula
- C14H20N2O3
- Molecular Weight
- 264.1473925 g/mol
- Structure
-
- IUPAC Name
- benzyl N-[(1S,2R)-1-carbamoyl-2-methyl-butyl]carbamate
- InChI
- InChI=1S/C14H20N2O3/c1-3-10(2)12(13(15)17)16-14(18)19-9-11-7-5-4-6-8-11/h4-8,10,12H,3,9H2,1-2H3,(H2,15,17)(H,16,18)/t10-,12+/m1/s1
- InChI Key
- PDGQPWKDTCRXMR-PWSUYJOCSA-N
- SMILES
- CC[C@@H](C)[C@H](NC(=O)OCc1ccccc1)C(N)=O
- Source
- ZINC000034319259
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 19 | Ring Count | 1 |
Heteroatom Count | 5 | Rotatable Bond Count | 6 |
Hydrogen Bond Acceptor Count | 3 | Hydrogen Bond Donor Count | 2 |
Topological Polar Surface Area | 81.42 Å2 | LogP | 2.052 |
LogS | -2.913 | LogD | 2.317 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.009 | Pgp substrate | 0.005 |
HIA | 0.966 | F20 % | 0.994 |
F30 % | 0.9 | Caco-2 | -4.774 |
MDCK | -4.556 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.861 | PPB | 64.051 |
VD | 0.538 | Fu | 0.579 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.019 | CYP1A2 substrate | 0.746 |
CYP2A6 substrate | 0.598 | CYP2B6 substrate | 0.606 |
CYP2C19 inhibitor | 0.163 | CYP2C19 substrate | 0.918 |
CYP2C8 substrate | 0.826 | CYP2C9 inhibitor | 0.098 |
CYP2C9 substrate | 0.997 | CYP2D6 inhibitor | 0.014 |
CYP2D6 substrate | 0.872 | CYP2E1 substrate | 0.487 |
CYP3A4 inhibitor | 0.009 | CYP3A4 substrate | 0.987 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.551 | CL | 8.134 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.002 | Hepatotoxicity | 0.59 |
Mutagenicity | 0.059 | Rat Oral Acute Toxicity | 0.029 |
FDAMDD | 0.073 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.037 | Eye Corrosion | 0.004 |
Eye Irritation | 0.295 | Respiratory Toxicity | 0.003 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.24 | IGC50 | 2.666 |
LC50FM | 3.404 | LC50DM | 4.857 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.12 | NR-AR-LBD | 0.224 |
NR-AhR | 0.004 | NR-Aromatase | 0.051 |
NR-ER | 0.276 | NR-ER-LBD | 0.333 |
NR-PPAR-gamma | 0.19 | SR-ARE | 0.035 |
SR-ATAD5 | 0.289 | SR-HSE | 0.098 |
SR-MMP | 0.008 | SR-p53 | 0.017 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.